ArticlePloS one2026
Automated quantification of central corneal epithelial thickness for the diagnosis of limbal stem cell deficiency.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Limbal Stem Cell Deficiency (LSCD) is a corneal disorder characterized by conjunctivalization of the cornea. Central corneal epithelial thickness, measured using Anterior Segment Optical Coherence Tomography (AS-OCT), is a biomarker for LSCD. Manual measurement of epithelial thickness remains the gold standard for diagnosis because existing automated commercial software is unreliable in severe cases. Standard machine learning approaches have limited applicability for automating this measurement due to the difficulty of distinguishing corneal epithelium from scar tissue, and imprecise clinical labels. The goal of this study is to develop a deep learning pipeline to automate measurement of central epithelial thickness in AS-OCT images of eyes with LSCD. To accomplish this goal, we developed AI-CE, a model based on Multi-scale U-Net (MSU-Net) trained to accurately delineate the epithelial layer. The primary dataset comprised of 134 patient eyes, including 47 healthy normal eyes (35.0%), 34 with Stage 1 (25.4%), 34 with Stage 2 (25.4%), and 19 with Stage 3 (14.2%) LSCD. Performance was evaluated by calculating the average mean absolute error between model segmentations and manually measured clinical assessments. AI-CE model performance was compared against a commercially available segmentation software to demonstrate its improvement over the current state-of-the-art. The proposed model achieved a mean absolute error of 5.10 μm, significantly improving (p < 0.01) over clinical software (12.20 μm). This result was verified in a secondary retrospective dataset which similarly showed significant improvement over commercial software. We also demonstrate that clinical epithelial thickness values provided by AI-CE can distinguish between LSCD stages similarly to manual evaluations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.